MTOR and acute lymphoblastic leukemia: The PI3K/AKT/mTOR (phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin) signaling pathway was found to be constitutively activated in various solid cancers and the majority of hematological malignancies, including ALL [3].